Skip to main content
. 2023 Mar 22;61(4):e01816-22. doi: 10.1128/jcm.01816-22

TABLE 1.

Demographic characteristics of the included participants living with HIV in the studya

Characteristics All Participants with:
CD4 count, <500 CD4 count, ≥500
No. of participants 350 268 82
Median age, yrs (IQR) 38.0 (32.0–46.0) 38.0 (32.0–46.0) 37.0 (32.0–44.0)
Sex
 Male 314 (89.7) 244 (91.0) 70 (85.4)
 Female 36 (10.3) 24 (9.0) 12 (14.6)
Median BMI (IQR) 22.2 (20.6–23.9) 22.0 (20.3–23.8) 22.8 (21.5–24.2)
Race
 Han 301 (89.7) 233 (87.6) 68 (82.9)
 Minority 47 (10.3) 33 (12.4) 14 (17.1)
BCG vaccination
 No 190 (54.6) 145 (54.5) 45 (54.9)
 Yes 158 (45.4) 121 (45.5) 37 (45.1)
Previous incarceration history
 No 251 (72.1) 190 (71.4) 61 (74.4)
 Yes 97 (27.9) 76 (28.6) 21 (25.6)
Median incarceration time, mo (IQR) 31.5 (13.0–55.8) 29.0 (11.5–52.0) 41.0 (19.8–63.5)
Median EC, mm (IQR) 0.0 (0.0–1.0) 0.0 (0.0–1.0) 0.0 (0.0–1.0)
QFT
 Positive 89 (25.4) 67 (25.0) 22 (26.9)
 Negative 254 (72.6) 195 (72.8) 59 (72.0)
 Indeterminate 7 (0.0) 6 (2.2) 1 (1.2)
TST
 Positive 59 (16.9) 42 (15.7) 17 (20.7)
 Negative 291 (83.1) 226 (84.3) 65 (79.3)
Median QFT (IQR) 0.01 (–0.01–0.97) 0.01 (0.00–0.59) 0.01 (–0.02–3.35)
Median TST (IQR) 0.0 (0.0–1.0) 0.0 (0.0–1.0) 0.0 (0.0–1.0)
a

Data indicate medians with interquartile ranges (IQR) or the numbers (%). BMI, body mass index; EC, ESAT6-CFP10; TST, tuberculin skin test; QFT, QuantiFERON-TB Gold In-Tube test; BCG, bacillus Calmette-Guérin.